Pay in 4 interest-free payments of $5.35 Learn more
Ships within 48 hours · Estimated delivery Aug 5 - Aug 10
GLP-1R Agonist Exendin-4 Protects Against Hemorrhagic Transformation Induced by rtPA After Ischemic Stroke via the Wnt/beta-Catenin Signaling Pathway
PMCID: PMC7913862
AOD9604 is classified under the Peptide Hormones and Related Substances category by WADA, making it a banned compound in all forms of competitive athletics. World AntiDoping Agency Disclaimer The content in this article is provided for educational and informational purposes only
Krouse RS, Royal RE, Heywood G, Weintraub BD, White DE, Steinberg SM, Rosenberg SA, Schwartzentruber DJ
Leveraging human genetic data to investigate the cardiometabolic effects of glucose-dependent insulinotropic polypeptide signalling
US$ 23.27
US$ 27.71
US$ 29.18
US$ 26.51
US$ 26.31
US$ 22.33
US$ 28.97
US$ 20.49
US$ 28.11
